Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Insights into chemopreventive effects of rosmarinic acid against aflatoxin B1-induced genotoxic effects
Authors:ID Furlan, Veronika (Author)
ID Novak, Matjaž (Author)
ID Štampar, Martina (Author)
ID Štern, Alja (Author)
ID Žegura, Bojana (Author)
ID Bren, Urban (Author)
Files:URL URL - Source URL, visit https://doi.org/10.3390/foods14122111
 
.pdf PDF - Presentation file, download (1,41 MB)
MD5: 1E545E41B201D6B9041FA2E96E908A93
 
.zip ZIP - Supplement, download (350,06 KB)
MD5: 7A75CB92CDF722848BD23140E88C6FB0
Description: Supplementary materials
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo NIB - National Institute of Biology
Abstract:In this study, the chemopreventive effects of rosmarinic acid (RA), a major phenolic acid of the plant Rosmarinus officinalis L., against the carcinogenic naturally occurring mycotoxin aflatoxin B1 (AFB1) were investigated using both in silico and in vitro approaches. The in silico investigation of the chemical reactions between rosmarinic acid and the carcinogenic metabolite of AFB1, aflatoxin B1 exo-8,9-epoxide (AFBO), was conducted by activation free energies calculations with DFT functionals M11-L and MN12-L, in conjunction with the 6-311++G(d,p) flexible basis set and implicit solvation model density (SMD), according to a newly developed quantum mechanics-based protocol for the evaluation of carcinogen scavenging activity (QM-CSA). Following the computational analyses, the chemoprotective effects of RA were further studied in vitro in human hepatocellular carcinoma HepG2 cells by analyzing its influence on AFB1-induced genotoxicity using a comet assay, γH2AX, and p-H3, while its impact on cell proliferation and cell cycle modulation was assessed using flow cytometry. Our computational results revealed that the activation free energy required for the reaction of RA with AFBO (14.86 kcal/mol) is significantly lower than the activation free energy for the competing reaction of AFBO with guanine (16.88 kcal/mol), which indicates that RA acts as an efficient natural scavenger of AFBO, potentially preventing AFB1-specific DNA adduct formation. The chemoprotective activity of RA was confirmed through in vitro experiments, which demonstrated a statistically significant (p < 0.05) reduction in AFB1-induced single- and double-strand breaks in HepG2 cells exposed to a mixture of AFB1 and RA at non-cytotoxic concentrations. In addition, RA reversed the AFB1-induced reduction in cell proliferation.
Keywords:rosmarinic acid, aflatoxin B1, chemopreventive effects, antigenotoxic effects, density functional theory, chemical carcinogen scavenger, toxicology
Publication status:Published
Publication version:Version of Record
Publication date:16.06.2025
Year of publishing:2025
Number of pages:str. [1]-17
Numbering:iss. 12, art. no. ǂ2111
PID:20.500.12556/DiRROS-22854 New window
UDC:615.9
ISSN on article:2304-8158
DOI:10.3390/foods14122111 New window
COBISS.SI-ID:241332995 New window
Note:Soavtorji: Matjaž Novak, Martina Štampar, Alja Štern, Bojana Žegura and Urban Bren; Nasl. z nasl. zaslona; Opis vira z dne 3. 7. 2025;
Publication date in DiRROS:03.07.2025
Views:490
Downloads:390
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Foods
Shortened title:Foods
Publisher:MDPI
ISSN:2304-8158
COBISS.SI-ID:512252472 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z4-60176-2025
Name:Mehanistični vpogled v antikarcinogeno, antioksidativno in antimikrobno delovanje naravnih polifenolnih spojin iz laškega smilja

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:L7-60161-2025
Name:Razvoj elektrokemijskega biosenzorja za detekcijo metil živega srebra

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J2-60044-2025
Name:Računalniško podprto okolje za sistematično sintezo, načrtovanje in vključevanje pretočne kemije in mikroprocesov v trajnostne proizvodne sisteme, ciljano na Moč-do-X

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-60001-2025
Name:Raziskovanje analgetičnega potenciala herkinorina: celostni pristop k varnejšim opioidom

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0046-2019
Name:Separacijski procesi in produktna tehnika

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0403-2019
Name:Računsko intenzivni kompleksni sistemi

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0438-2022
Name:Optični kemijski/bio senzorski sistemi (OPTISENS)

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0245-2019
Name:Ekotoksiologija, toksikološka genomika in karcinogeneza

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-4398-2022
Name:Kemijska karcinogeneza in nevrodegeneracija: Molekularni mehanizem vpliva mikrovalovnega sevanja

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:L2-4430-2022
Name:Proizvodnja, izolacija in formulacija zdravju koristnih substanc iz Helichrysum Italicum za uporabo v kozmetični industriji

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4498-2022
Name:Multi-omska raziskava signalne poti NFkB pri multipli sklerozi

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-4638-2022
Name:Načrtovanje selektivnih katalitskih postopkov pretvorbe CO2 v etanol – UliSess

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-4414-2022
Name:ProBiS-Fold pristop za določanje vezavnih mest za celoten strukturni človeški proteom pri odkrivanju zdravil

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4497-2022
Name:Neinvazivni multi-omski biooznačevalci v podtipih imunskih celic za personalizirano zdravljenje otroške astme in molekularni mehanizmi neodzivnosti na inhalacijske kortikosteroide

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J4-4633-2023
Name:Razumevanje mehanizmov in preprečevanje agregacije biofarmacevtskih proteinov

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-50034-2023
Name:Knjižnica korelacij med vezavnimi vzorci opioidov in njihovimi neželenimi stranskimi učinki

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-50043-2023
Name:Mutacijska platforma koronavirusnih terapevtskih tarč za študij vpliva mutacij na učinkovitost in izbiro zdravil ter načrtovanje novih pan-koronavirusnih zaviralcev

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-60016-2025
Name:Mikotoksini in njihove kompleksne mešanice: pomen za zdravje ljudi zaradi izpostavljenosti kontaminirani hrani

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-E015-2024
Name:Izvajanje mednarodnega infrastrukturnega projekta BBMRI

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:PR-13066-6
Name:Razvoj odpornega kemijskega shranjevanja energije z vodikom in baterijami
Acronym:HyBReED

Funder:ANR - French National Research Agency
Funding programme:French National Research Agency (ANR)
Project number:ANR-21-FAI1-0001
Name:A hybrid AI approach for understanding science in online discourse
Acronym:AI4SCI

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:rožmarinska kislina, aflratoksin B1, kemoprotektivni učinki, antigenotoskični učinki, toksikologija


Back